Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTIST-1: Resistance Exercise in Critical Illness
NCT05197231Suspended
- Sponsor
- Karolinska University Hospital
- Start
- Dec 2022
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Change in lower limb protein balance. Started Dec 2022; status: suspended.
Beyond the preview
Go deeper on NCT05197231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05197231.